未登录

M

Marián Castro

cedars-sinai medical center

H指数:28

被引数:3,251

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand

合成、实验与计算评价SERAAK1作为5-HT2A受体配体的研究

IF4.6

2025-05-140

OA

Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome

与 Leigh 综合征相关的复合杂合 MRPS14 变体

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

IF3.9

2025-05-020

OAAI

Biochemical changes precede affective and cognitive anomalies in aging adult C57BL/6J mice with a prior history of adolescent alcohol binge-drinking

ADDICTION BIOLOGY

IF2.6

2024-12-120

OA

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening

通过虚拟筛选鉴定的新型5-羟色胺5-HT2A受体配体的发现和体外评估

IF3.4

2024-05-291

PRE

2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives

IF4.6

2024-05-280

OAAI

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia

IF4.6

2023-05-200

OAAI

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2023-05-154

OAAI

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents-Design, synthesis, structural studies and pharmacological profiling

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-04-014

PRE

Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety

IF3.4

2022-06-175

PRE

In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1

NEUROCHEMICAL RESEARCH

IF3.8

2022-04-053

PRE

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties

IF4.6

2022-02-153

OAAI

Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications

PHARMACOLOGICAL REPORTS

IF3.8

2022-01-224

OAAI

N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl} propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand

NEUROCHEMISTRY INTERNATIONAL

IF4

2021-06-0111

PREAI

Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-04-0115

OAAI

Essential role of the C148-C227 disulphide bridge in the human 5-HT2A homodimeric receptor

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-07-014

PREAI

1-(2′-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors

JOURNAL OF NATURAL PRODUCTS

IF3.6

2020-01-1410

PREAI

Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-10-0122

PREAI

2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships

2-芳基腺嘌呤衍生物作为A1，A3和双A1/A3腺苷受体拮抗剂的有效支架: 合成和构效关系

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-08-014

PREAI

New Nitrogen Compounds Coupled to Phenolic Units with Antioxidant and Antifungal Activities: Synthesis and Structure-Activity Relationship

IF4.6

2018-10-039

OAAI

Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D2 Receptor Ligand

IF4.6

2018-09-0411

OAAI